CCR2 and cancer: Promising results from PET studies using [68Ga]pentixafor (14), [64Cu]DOTA-ECL1i (1), and [64Cu]DOTA-DAPTA-comb (5) expanded the boundaries of cancer and cardiac disorder imaging for CXCR4, CCR2, and CCR5, respectively.